 | | A1BV5 | | Name: | N-(6-amino-5-cyclopropylpyridin-3-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide | | Formula: | C23 H25 N5 O2 S | | SMILES: | Nc1ncc(cc1C1CC1)NC(=O)C(=O)N1CC(C)CCC1c1cc2ncsc2cc1 | | InChi: | InChI=1S/C23H25N5O2S/c1-13-2-6-19(15-5-7-20-18(8-15)26-12-31-20)28(11-13)23(30)22(29)27-16-9-17(14-3-4-14)21(24)25-10-16/h5,7-10,12-14,19H,2-4,6,11H2,1H3,(H2,24,25)(H,27,29)/t13-,19+/m0/s1 | | Definition date: | 2025-02-03 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | N-(6-amino-5-cyclopropylpyridin-3-yl)-2-[(2R,5S)-2-(1,3-benzothiazol-5-yl)-5-methylpiperidin-1-yl]-2-oxoacetamide |
|
 | | A1D6U | | Name: | ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine | | Formula: | C12 H17 Cu N4 S | | SMILES: | CC(C)C1=[N+]2N=C(S[Cu]2[n+]3ccccc13)N(C)C | | InChi: | InChI=1S/C12H18N4S.Cu/c1-9(2)11(10-7-5-6-8-13-10)14-15-12(17)16(3)4 | | Definition date: | 2024-03-15 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine |
|
 | | A1D9R | | Name: | (2~{S})-2-[[6-methoxy-2-[(2-methyl-3-phenyl-phenyl)amino]pyrimidin-4-yl]methylamino]-3-oxidanyl-propanoic acid | | Formula: | C22 H24 N4 O4 | | SMILES: | COc1cc(CN[CH](CO)C(O)=O)nc(Nc2cccc(c2C)c3ccccc3)n1 | | InChi: | InChI=1S/C22H24N4O4/c1-14-17(15-7-4-3-5-8-15)9-6-10-18(14)25-22-24-16(11-20(26-22)30-2)12-23-19(13-27)21(28)29/h3-11,19,23,27H,12-13H2,1-2H3,(H,28,29)(H,24,25,26)/t19-/m0/s1 | | Definition date: | 2024-07-09 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | (2~{S})-2-[[6-methoxy-2-[(2-methyl-3-phenyl-phenyl)amino]pyrimidin-4-yl]methylamino]-3-oxidanyl-propanoic acid |
|
 | | A1EDM | | Name: | (6~{S})-1-(3-chloranyl-4-methoxy-phenyl)-6-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{S})-2-morpholin-4-ylpropyl]imidazol-2-yl]piperidin-2-one | | Formula: | C30 H34 Cl N5 O4 | | SMILES: | COc1ccc(cc1Cl)N2[CH](CCCC2=O)c3nc(cn3C[CH](C)N4CCOCC4)c5ccc6onc(C)c6c5 | | InChi: | InChI=1S/C30H34ClN5O4/c1-19(34-11-13-39-14-12-34)17-35-18-25(21-7-9-27-23(15-21)20(2)33-40-27)32-30(35)26-5-4-6-29(37)36(26)22-8-10-28(38-3)24(31)16-22/h7-10,15-16,18-19,26H,4-6,11-14,17H2,1-3H3/t19-,26-/m0/s1 | | Definition date: | 2024-10-14 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | (6~{S})-1-(3-chloranyl-4-methoxy-phenyl)-6-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{S})-2-morpholin-4-ylpropyl]imidazol-2-yl]piperidin-2-one |
|
 | | A1EDN | | Name: | (5~{S})-1-(3-chloranyl-4-methoxy-phenyl)-5-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{R})-2-morpholin-4-ylpropyl]imidazol-2-yl]pyrrolidin-2-one | | Formula: | C29 H32 Cl N5 O4 | | SMILES: | COc1ccc(cc1Cl)N2[CH](CCC2=O)c3nc(cn3C[CH](C)N4CCOCC4)c5ccc6onc(C)c6c5 | | InChi: | InChI=1S/C29H32ClN5O4/c1-18(33-10-12-38-13-11-33)16-34-17-24(20-4-7-26-22(14-20)19(2)32-39-26)31-29(34)25-6-9-28(36)35(25)21-5-8-27(37-3)23(30)15-21/h4-5,7-8,14-15,17-18,25H,6,9-13,16H2,1-3H3/t18-,25+/m1/s1 | | Definition date: | 2024-10-14 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | (5~{S})-1-(3-chloranyl-4-methoxy-phenyl)-5-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{R})-2-morpholin-4-ylpropyl]imidazol-2-yl]pyrrolidin-2-one |
|
 | | A1EDO | | Name: | (5~{S})-1-(3-chloranyl-4-methoxy-phenyl)-5-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{S})-2-morpholin-4-ylpropyl]imidazol-2-yl]pyrrolidin-2-one | | Formula: | C29 H32 Cl N5 O4 | | SMILES: | COc1ccc(cc1Cl)N2[CH](CCC2=O)c3nc(cn3C[CH](C)N4CCOCC4)c5ccc6onc(C)c6c5 | | InChi: | InChI=1S/C29H32ClN5O4/c1-18(33-10-12-38-13-11-33)16-34-17-24(20-4-7-26-22(14-20)19(2)32-39-26)31-29(34)25-6-9-28(36)35(25)21-5-8-27(37-3)23(30)15-21/h4-5,7-8,14-15,17-18,25H,6,9-13,16H2,1-3H3/t18-,25-/m0/s1 | | Definition date: | 2024-10-14 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | (5~{S})-1-(3-chloranyl-4-methoxy-phenyl)-5-[4-(3-methyl-1,2-benzoxazol-5-yl)-1-[(2~{S})-2-morpholin-4-ylpropyl]imidazol-2-yl]pyrrolidin-2-one |
|
 | | A1EF5 | | Name: | 3-[[2,6-bis(chloranyl)-4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]amino]thiophene-2-carboxylic acid | | Formula: | C16 H13 Cl2 N3 O2 S | | SMILES: | Cc1[nH]nc(C)c1c2cc(Cl)c(Nc3ccsc3C(O)=O)c(Cl)c2 | | InChi: | InChI=1S/C16H13Cl2N3O2S/c1-7-13(8(2)21-20-7)9-5-10(17)14(11(18)6-9)19-12-3-4-24-15(12)16(22)23/h3-6,19H,1-2H3,(H,20,21)(H,22,23) | | Definition date: | 2024-11-22 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 3-[[2,6-bis(chloranyl)-4-(3,5-dimethyl-1~{H}-pyrazol-4-yl)phenyl]amino]thiophene-2-carboxylic acid |
|
 | | A1EIV | | Name: | [(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-(3-sulfanylpyridin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate | | Formula: | C10 H15 N O7 P S | | SMILES: | O[CH]1[CH](O)[CH](O[CH]1CO[P](O)(O)=O)[n+]2cccc(S)c2 | | InChi: | InChI=1S/C10H14NO7PS/c12-8-7(5-17-19(14,15)16)18-10(9(8)13)11-3-1-2-6(20)4-11/h1-4,7-10,12-13H,5H2,(H2-,14,15,16,20)/p+1/t7-,8-,9-,10-/m1/s1 | | Definition date: | 2024-12-31 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-(3-sulfanylpyridin-1-ium-1-yl)oxolan-2-yl]methyl dihydrogen phosphate |
|
 | | A1IHE | | Name: | 2-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-3-prop-2-ynoxy-oxan-4-yl]oxymethyl]-3-methyl-benzimidazole-5-carboxylic acid | | Formula: | C25 H24 Cl2 N2 O7 S | | SMILES: | Cn1c(CO[CH]2[CH](O)[CH](CO)O[CH](Sc3ccc(Cl)c(Cl)c3)[CH]2OCC#C)nc4ccc(cc14)C(O)=O | | InChi: | InChI=1S/C25H24Cl2N2O7S/c1-3-8-34-23-22(35-12-20-28-17-7-4-13(24(32)33)9-18(17)29(20)2)21(31)19(11-30)36-25(23)37-14-5-6-15(26)16(27)10-14/h1,4-7,9-10,19,21-23,25,30-31H,8,11-12H2,2H3,(H,32,33)/t19-,21+,22+,23-,25-/m1/s1 | | Definition date: | 2024-07-08 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 2-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-3-prop-2-ynoxy-oxan-4-yl]oxymethyl]-3-methyl-benzimidazole-5-carboxylic acid |
|
 | | A1ISY | | Name: | 5-methyl-4-phenyl-1H-pyrazol-3-amine | | Formula: | C10 H11 N3 | | SMILES: | Cc1[nH]nc(N)c1c2ccccc2 | | InChi: | InChI=1S/C10H11N3/c1-7-9(10(11)13-12-7)8-5-3-2-4-6-8/h2-6H,1H3,(H3,11,12,13) | | Definition date: | 2024-10-28 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 5-methyl-4-phenyl-1~{H}-pyrazol-3-amine |
|
 | | A1IWO | | Name: | 1-[5-chloranyl-4-[(3~{R})-pyrrolidin-3-yl]oxy-pyrimidin-2-yl]benzimidazole | | Formula: | C15 H14 Cl N5 O | | SMILES: | Clc1cnc(nc1O[CH]2CCNC2)n3cnc4ccccc34 | | InChi: | InChI=1S/C15H14ClN5O/c16-11-8-18-15(20-14(11)22-10-5-6-17-7-10)21-9-19-12-3-1-2-4-13(12)21/h1-4,8-10,17H,5-7H2 | | Definition date: | 2024-12-18 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 1-[5-chloranyl-4-[(3~{R})-pyrrolidin-3-yl]oxy-pyrimidin-2-yl]benzimidazole |
|
 | | A1L2F | | Name: | [(2~{R})-1-octadecanoyloxy-3-[oxidanyl-[(2~{R},3~{S},5~{R},6~{R})-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] nonadecanoate | | Formula: | C46 H90 O16 P2 | | SMILES: | CCCCCCCCCCCCCCCCCCC(=O)O[CH](COC(=O)CCCCCCCCCCCCCCCCC)CO[P](O)(=O)O[CH]1[CH](O)[CH](O)[CH](O[P](O)(O)=O)[CH](O)[CH]1O | | InChi: | InChI=1S/C46H90O16P2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-40(48)60-38(36-58-39(47)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)37-59-64(56,57)62-46-43(51)41(49)45(42(50)44(46)52)61-63(53,54)55/h38,41-46,49-52H,3-37H2,1-2H3,(H,56,57)(H2,53,54,55)/t38-,41-,42+,43-,44-,45-,46+/m1/s1 | | Definition date: | 2024-06-13 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | [(2~{R})-1-octadecanoyloxy-3-[oxidanyl-[(2~{R},3~{S},5~{R},6~{R})-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propan-2-yl] nonadecanoate |
|
 | | A1L6B | | Name: | 7-[2-azanyl-3,4,5,6-tetrakis(fluoranyl)phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile | | Formula: | C31 H26 Cl F4 N7 O2 | | SMILES: | CC(C)c1nccc(C)c1N2C(=O)C(=C(N3CCN(CC3)C(=O)C=C)c4cc(Cl)c(nc24)c5c(N)c(F)c(F)c(F)c5F)C#N | | InChi: | InChI=1S/C31H26ClF4N7O2/c1-5-19(44)41-8-10-42(11-9-41)29-16-12-18(32)27(20-21(33)22(34)23(35)24(36)25(20)38)40-30(16)43(31(45)17(29)13-37)28-15(4)6-7-39-26(28)14(2)3/h5-7,12,14H,1,8-11,38H2,2-4H3 | | Definition date: | 2024-11-25 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 7-[2-azanyl-3,4,5,6-tetrakis(fluoranyl)phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile |
|
 | | A1L6C | | Name: | 7-[2-azanyl-3,5-bis(chloranyl)-6-fluoranyl-phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile | | Formula: | C31 H27 Cl3 F N7 O2 | | SMILES: | CC(C)c1nccc(C)c1N2C(=O)C(=C(N3CCN(CC3)C(=O)C=C)c4cc(Cl)c(nc24)c5c(N)c(Cl)cc(Cl)c5F)C#N | | InChi: | InChI=1S/C31H27Cl3FN7O2/c1-5-22(43)40-8-10-41(11-9-40)29-17-12-21(34)27(23-24(35)19(32)13-20(33)25(23)37)39-30(17)42(31(44)18(29)14-36)28-16(4)6-7-38-26(28)15(2)3/h5-7,12-13,15H,1,8-11,37H2,2-4H3 | | Definition date: | 2024-11-26 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 7-[2-azanyl-3,5-bis(chloranyl)-6-fluoranyl-phenyl]-6-chloranyl-1-(4-methyl-2-propan-2-yl-pyridin-3-yl)-2-oxidanylidene-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile |
|
 | | A1LZB | | Name: | 7-[2-(cyclopropylmethoxy)phenyl]-5-methyl-2-[(1-methylsulfonylpiperidin-4-yl)methyl]pyrazolo[4,3-c]pyridin-4-one | | Formula: | C24 H30 N4 O4 S | | SMILES: | CN1C=C(c2ccccc2OCC3CC3)c4nn(CC5CCN(CC5)[S](C)(=O)=O)cc4C1=O | | InChi: | InChI=1S/C24H30N4O4S/c1-26-14-20(19-5-3-4-6-22(19)32-16-18-7-8-18)23-21(24(26)29)15-27(25-23)13-17-9-11-28(12-10-17)33(2,30)31/h3-6,14-15,17-18H,7-13,16H2,1-2H3 | | Definition date: | 2024-03-18 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 7-[2-(cyclopropylmethoxy)phenyl]-5-methyl-2-[(1-methylsulfonylpiperidin-4-yl)methyl]pyrazolo[4,3-c]pyridin-4-one |
|
 | | A1LZE | | Name: | 5-methyl-2-{[(2R)-2-methyl-4-methylsulfonyl-piperazin-1-yl]methyl}-7-(1-methylpyrazol-3-yl)furo[3,2-c]pyridin-4-one | | Formula: | C19 H25 N5 O4 S | | SMILES: | C[CH]1CN(CCN1Cc2oc3C(=CN(C)C(=O)c3c2)c4ccn(C)n4)[S](C)(=O)=O | | InChi: | InChI=1S/C19H25N5O4S/c1-13-10-24(29(4,26)27)8-7-23(13)11-14-9-15-18(28-14)16(12-21(2)19(15)25)17-5-6-22(3)20-17/h5-6,9,12-13H,7-8,10-11H2,1-4H3/t13-/m1/s1 | | Definition date: | 2024-03-18 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 5-methyl-2-[[(2~{R})-2-methyl-4-methylsulfonyl-piperazin-1-yl]methyl]-7-(1-methylpyrazol-3-yl)furo[3,2-c]pyridin-4-one |
|
 | | A1LZF | | Name: | 2-{[(3S)-1-benzylpyrrolidin-3-yl]methyl}-5-methyl-7-(1-methylpyrazol-3-yl)pyrazolo[4,3-c]pyridin-4-one | | Formula: | C23 H26 N6 O | | SMILES: | Cn1ccc(n1)C2=CN(C)C(=O)c3cn(C[CH]4CCN(C4)Cc5ccccc5)nc23 | | InChi: | InChI=1S/C23H26N6O/c1-26-15-19(21-9-10-27(2)24-21)22-20(23(26)30)16-29(25-22)14-18-8-11-28(13-18)12-17-6-4-3-5-7-17/h3-7,9-10,15-16,18H,8,11-14H2,1-2H3/t18-/m0/s1 | | Definition date: | 2024-03-18 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | 5-methyl-7-(1-methylpyrazol-3-yl)-2-[[(3~{S})-1-(phenylmethyl)pyrrolidin-3-yl]methyl]pyrazolo[4,3-c]pyridin-4-one |
|
 | | A1LZZ | | Name: | (4R,6S)-N-cyclohexyl-1-methyl-6-[[5-methyl-7-(1-methylpyrazol-3-yl)-4-oxidanylidene-pyrazolo[4,3-c]pyridin-2-yl]methyl]azepane-4-carboxamide | | Formula: | C26 H37 N7 O2 | | SMILES: | CN1CC[CH](C[CH](C1)Cn2cc3C(=O)N(C)C=C(c4ccn(C)n4)c3n2)C(=O)NC5CCCCC5 | | InChi: | InChI=1S/C26H37N7O2/c1-30-11-9-19(25(34)27-20-7-5-4-6-8-20)13-18(14-30)15-33-17-22-24(29-33)21(16-31(2)26(22)35)23-10-12-32(3)28-23/h10,12,16-20H,4-9,11,13-15H2,1-3H3,(H,27,34)/t18-,19-/m0/s1 | | Definition date: | 2024-04-01 | | Last modified: | 2025-03-07 | | Release date: | 2025-03-12 | | Identifier: | (4~{R},6~{S})-~{N}-cyclohexyl-1-methyl-6-[[5-methyl-7-(1-methylpyrazol-3-yl)-4-oxidanylidene-pyrazolo[4,3-c]pyridin-2-yl]methyl]azepane-4-carboxamide |
|
 | | X92 | | Name: | Ramiprilat | | Formula: | C21 H28 N2 O5 | | SMILES: | C[CH](N[CH](CCc1ccccc1)C(O)=O)C(=O)N2[CH]3CCC[CH]3C[CH]2C(O)=O | | InChi: | InChI=1S/C21H28N2O5/c1-13(22-16(20(25)26)11-10-14-6-3-2-4-7-14)19(24)23-17-9-5-8-15(17)12-18(23)21(27)28/h2-4,6-7,13,15-18,22H,5,8-12H2,1H3,(H,25,26)(H,27,28)/t13-,15-,16-,17-,18-/m0/s1 | | Definition date: | 2010-03-14 | | Last modified: | 2025-03-05 | | Identifier: | (2~{S},3~{a}~{S},6~{a}~{S})-1-[(2~{S})-2-[[(2~{S})-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-3,3~{a},4,5,6,6~{a}-hexahydro-2~{H}-cyclopenta[b]pyrrole-2-carboxylic acid |
|
 | | 2MA | | Name: | 2-METHYLADENOSINE-5'-MONOPHOSPHATE | | Formula: | C11 H16 N5 O7 P | | SMILES: | O=P(O)(O)OCC1OC(n2cnc3c(N)nc(C)nc32)C(O)C1O | | InChi: | InChI=1S/C11H16N5O7P/c1-4-14-9(12)6-10(15-4)16(3-13-6)11-8(18)7(17)5(23-11)2-22-24(19,20)21/h3,5,7-8,11,17-18H,2H2,1H3,(H2,12,14,15)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2025-03-05 | | Identifier: | 2-methyladenosine 5'-(dihydrogen phosphate) |
|
 | | TCA | | Name: | PHENYLETHYLENECARBOXYLIC ACID | | Formula: | C9 H8 O2 | | SMILES: | O=C(O)C=Cc1ccccc1 | | InChi: | InChI=1S/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11)/b7-6+ | | Definition date: | 1999-07-08 | | Last modified: | 2025-02-28 | | Identifier: | (2E)-3-phenylprop-2-enoic acid |
|
 | | 86T | | Name: | metyltetraprole | | Formula: | C19 H17 Cl N6 O2 | | SMILES: | CN1N=NN(C1=O)c2cccc(C)c2COc3cnn(c3)c4ccc(Cl)cc4 | | InChi: | InChI=1S/C19H17ClN6O2/c1-13-4-3-5-18(26-19(27)24(2)22-23-26)17(13)12-28-16-10-21-25(11-16)15-8-6-14(20)7-9-15/h3-11H,12H2,1-2H3 | | Synonyms: | 44WE6KNK7M | | Definition date: | 2023-03-17 | | Last modified: | 2025-02-28 | | Release date: | 2025-03-05 | | Identifier: | 1-[2-[[1-(4-chlorophenyl)pyrazol-4-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-1,2,3,4-tetrazol-5-one |
|
 | | A1AOP | | Name: | 5-fluoro-N-[2-(methanesulfonyl)-4-(pyridin-4-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide | | Formula: | C21 H17 F N2 O4 S3 | | SMILES: | CS(=O)(=O)c1cc(ccc1NS(=O)(=O)c1sc2ccc(F)cc2c1C)c1ccncc1 | | InChi: | InChI=1S/C21H17FN2O4S3/c1-13-17-12-16(22)4-6-19(17)29-21(13)31(27,28)24-18-5-3-15(11-20(18)30(2,25)26)14-7-9-23-10-8-14/h3-12,24H,1-2H3 | | Definition date: | 2024-04-19 | | Last modified: | 2025-02-28 | | Release date: | 2025-03-05 | | Identifier: | 5-fluoro-N-[2-(methanesulfonyl)-4-(pyridin-4-yl)phenyl]-3-methyl-1-benzothiophene-2-sulfonamide |
|
 | | A1AOQ | | Name: | 3-[2-(dimethylamino)-2-oxoethyl]-1-[(5-fluoro-1-benzothiophen-3-yl)methyl]-1H-indole-2-carboxylic acid | | Formula: | C22 H19 F N2 O3 S | | SMILES: | CN(C)C(=O)Cc1c2ccccc2n(Cc2csc3ccc(F)cc32)c1C(=O)O | | InChi: | InChI=1S/C22H19FN2O3S/c1-24(2)20(26)10-17-15-5-3-4-6-18(15)25(21(17)22(27)28)11-13-12-29-19-8-7-14(23)9-16(13)19/h3-9,12H,10-11H2,1-2H3,(H,27,28) | | Definition date: | 2024-04-19 | | Last modified: | 2025-02-28 | | Release date: | 2025-03-05 | | Identifier: | 3-[2-(dimethylamino)-2-oxoethyl]-1-[(5-fluoro-1-benzothiophen-3-yl)methyl]-1H-indole-2-carboxylic acid |
|
 | | A1AOU | | Name: | 1-[(7-fluoronaphthalen-1-yl)methyl]-1H-indole-2-carboxylic acid | | Formula: | C20 H14 F N O2 | | SMILES: | O=C(O)c1cc2ccccc2n1Cc1cccc2ccc(F)cc21 | | InChi: | InChI=1S/C20H14FNO2/c21-16-9-8-13-5-3-6-15(17(13)11-16)12-22-18-7-2-1-4-14(18)10-19(22)20(23)24/h1-11H,12H2,(H,23,24) | | Definition date: | 2024-04-19 | | Last modified: | 2025-02-28 | | Release date: | 2025-03-05 | | Identifier: | 1-[(7-fluoronaphthalen-1-yl)methyl]-1H-indole-2-carboxylic acid |
|
